Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

35.76
-0.0300-0.08%
Volume:7K
Turnover:255.87K
Market Cap:97.27M
PE:- -
High:36.45
Open:35.93
Low:35.76
Close:35.79
52wk High:36.84
52wk Low:23.42
Shares:2.72M
Float Shares:2.72M
Volume Ratio:1.02
T/O Rate:0.26%
Dividend:0.26
Dividend Rate:0.72%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply

Deep News
·
Aug 31

Healthcare Sector Sees Continued Positive Signals; CCB Fund Manager Liang Furui Highlights High-Prosperity Areas Such as Innovative Drugs

Deep News
·
Aug 31

New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform

Stock News
·
Aug 31

ABBISKO-B Initiates First Patient Dosing in Phase I Trial for Novel Pan-KRAS Inhibitor

Stock News
·
Aug 31

Three New Share Subscriptions Next Week Spanning AI Chip and Innovative Drug Hotspots; Nine IPOs This Year Have Already Delivered Over 100,000 Yuan Profit Per Lot

Deep News
·
Aug 30

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.
·
Aug 30

Bai Hua Pharma's Surge Halts After Doubling Within a Month, Company Clarifies Innovation Drug CRO Remains Minimal

Deep News
·
Aug 29

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

TIPRANKS
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Domestic Innovative Drug Sector Shifts From Cash Burn to Profit Generation as Mid-Year Reports Roll In

Deep News
·
Aug 28

Political and General News Events from August 28

Reuters
·
Aug 28

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Reuters
·
Aug 28

Shares of TYK Medicines-B Jump Nearly 15% in Morning Trading as Its Innovative Drug TY-9591 Receives Conditional Market Approval

Deep News
·
Aug 28

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Reuters
·
Aug 28

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

TIPRANKS
·
Aug 28